T2 Biosystems Shares Are Trading Lower After the Company Reported Worse-than-expected Q3 Revenue Results.

BenzingaNov 16 00:51

T2 Biosystems | 8-K: T2 Biosystems Announces Third Quarter 2024 Financial Results

SECNov 15 22:59

T2 Biosystems Reports Increased Losses and Cash Crunch

TipRanksNov 15 11:58

T2 Biosystems, Inc. (TTOO) Q3 2024 Earnings Call Transcript Summary

Futu NewsNov 15 07:20 · Conference Call

Express News | T2 Biosystems Rises 7.7% After the Bell Following Results

BreakingsNov 15 05:16

Express News | T2 Biosystems Inc: Outlook Q4 Total Sepsis Product Revenue of $2.5 Mln to $3.5 Mln

BreakingsNov 15 05:13